Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.

about

Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B.

P2860

Q40494788-A1EE164A-8CD6-4F3B-8A45-5910977F2730 Q41148991-2EAFC6F1-243F-4476-B5FD-7B6EE3EF4CF5

P2860

Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.

Item

http://www.wikidata.org/entity/Q42151600

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy of tenofovir switch therapy for nucleos

@nl

Efficacy of tenofovir switch t ...... ents with chronic hepatitis B.

@en

type

Item

label

Efficacy of tenofovir switch therapy for nucleos

@nl

Efficacy of tenofovir switch t ...... ents with chronic hepatitis B.

@en

prefLabel

Efficacy of tenofovir switch therapy for nucleos

@nl

Efficacy of tenofovir switch t ...... ents with chronic hepatitis B.

@en

P1476

Efficacy of tenofovir switch t ...... ents with chronic hepatitis B.

@en

P2093

A O-S Lo

http://www.w3.org/2001/XMLSchema#string

G L-H Wong

http://www.w3.org/2001/XMLSchema#string

H L-Y Chan

http://www.w3.org/2001/XMLSchema#string

H-Y Chan

http://www.w3.org/2001/XMLSchema#string

V W-S Wong

http://www.w3.org/2001/XMLSchema#string

Y-K Tse

http://www.w3.org/2001/XMLSchema#string

P2860

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B.

Efficacy of tenofovir disoproxil fumarate at 240 weeks in patients with chronic hepatitis B with high baseline viral load.

Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA.

The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.

Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.

No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B.

P304

1190-1199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.13185

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25825194

http://www.w3.org/2001/XMLSchema#string

Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.

about

P2860

P2860

Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698